BLA
发表于 2025-3-30 10:00:48
http://reply.papertrans.cn/79/7820/781945/781945_51.png
拱墙
发表于 2025-3-30 15:59:25
http://reply.papertrans.cn/79/7820/781945/781945_52.png
STAT
发表于 2025-3-30 17:15:12
http://reply.papertrans.cn/79/7820/781945/781945_53.png
allergen
发表于 2025-3-30 21:02:30
http://reply.papertrans.cn/79/7820/781945/781945_54.png
圣歌
发表于 2025-3-31 04:42:29
The Drug Development Process and Evolution of Regulations, to less than one in two . Less than 20 % of drugs entering phase-1 testing successfully reach the end of the three-phase evaluation. The percentage can vary from one specialty area to another and can be less than 5–10 % for oncologic and neurologic diseases .
REP
发表于 2025-3-31 09:02:52
http://reply.papertrans.cn/79/7820/781945/781945_56.png
切割
发表于 2025-3-31 09:56:01
The Definition of GCP,ant scientific and healthcare questions. Randomised controlled trials form the foundation for ‘evidence-based medicine’, but such research can be relied upon only if it is conducted according to principles and standards collectively referred to as ‘good clinical research practice’ (GCP) .
配置
发表于 2025-3-31 13:24:10
http://reply.papertrans.cn/79/7820/781945/781945_58.png
夜晚
发表于 2025-3-31 18:52:23
Setting the Ideal Method,ion, we need to consider the best strategy to address these questions. Further considerations in clinical research, such as the clinical setting, study design, selection criteria, data collection and analysis, are influenced by the disease characteristics, prevalence, time availability, expertise, research grants and several other factors .
青少年
发表于 2025-3-31 23:32:43
Book 2017l quality standard – Good Clinical Practice – provided by the International Conference on Harmonization (ICH). .The work offers an updated perspective on the clinical research landscape within the context of the clinical trial regulatory frameworks in Europe and the USA. In addition to providing a h